{
    "clinical_study": {
        "@rank": "72216", 
        "brief_summary": {
            "textblock": "Meibomian gland dysfunction (MGD) is a common and important disease has been investigated\n      the pathophysiology, diagnosis, treatment modalities of MGD, however, the changes of MGD\n      after the cataract surgery, the most popular surgery to ophthalmologist, had not been\n      evaluated. The investigators evaluated parameters related with MGD including lid margin\n      abnormalities, meibomian gland expressibility and meibography before and after surgery."
        }, 
        "brief_title": "Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Meibomian Gland Dysfunction", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1. Patients scheduled for cataract surgery\n\n        Exclusion Criteria:\n\n          1. other comorbid ocular diseases such as ocular allergies.\n\n          2. continuous use of topical ocular medications before surgery\n\n          3. histories of ocular surgery, or ocular injury\n\n          4. Already had severe obstructive MGD before surgery, abnormal findings on lid margin (>\n             3 positive findings), reduced meibum expression (> grade 2), and obstructed gland\n             dropout (meibography score > 3)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "88 Years", 
            "minimum_age": "45 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients scheduled for cataract surgery"
            }
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942642", 
            "org_study_id": "4-2012-0690"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography", 
        "lastchanged_date": "September 13, 2013", 
        "number_of_groups": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Ocular symptom score, lid margin abnormalities, superficial punctuate keratopathy, tear film break-up time, Shirmer's test, lower tear meniscus height (TMH), depth (TMD), and area (TMA), meibum expressibility, and meibography score", 
            "measure": "Ocular parameters", 
            "safety_issue": "No", 
            "time_frame": "change of Ocular parameters  from 1 to 3 months after cataract surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942642"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}